FDA
approval
· 2025-06-06
FDA Approved: LABETALOL HYDROCHLORIDE — Supplemental Application (Advagen Pharma Ltd)
Summary
FDA approves Advagen Pharma Ltd's supplemental application for labetalol hydrochloride (generic), updating the product's regulatory status.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for LABETALOL HYDROCHLORIDE (LABETALOL HYDROCHLORIDE)